Authors: Kaklamani, VG Nikolopoulou, N Sotsiou, F Billis, A Kaklamanis, P

Citation: Vg. Kaklamani et al., Renal involvement in Adamantiades-Behcet's disease. Case report and reviewof the literature, CLIN EXP RH, 19(5), 2001, pp. S55-S58

Authors: Sfikakis, PP Theodossiadis, PG Katsiari, CG Kaklamanis, P Markomichelakis, NN

Citation: Pp. Sfikakis et al., Effect of infliximab on sight-threatening panuveitis in Behcet's disease, LANCET, 358(9278), 2001, pp. 295-296

Authors: Zouboulis, CC Katsantonis, J Ketteler, R Treudler, R Kaklamani, E Hornemann, S Kaklamanis, P Orfanos, CE

Citation: Cc. Zouboulis et al., Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells, ARCH DERM R, 292(6), 2000, pp. 279-284

Authors: Kaklamani, VG Vaiopoulos, G Markomichelakis, N Kaklamanis, P

Citation: Vg. Kaklamani et al., Recurrent epididymo-orchitis in patients with Behcet's disease, J UROL, 163(2), 2000, pp. 487-489

Authors: Vaiopoulos, G Kaklamani, VG Markomichelakis, N Tzonou, A Mavrikakis, M Kaklamanis, P

Citation: G. Vaiopoulos et al., Clinical features of juvenile Adamantiades-Behcet's disease in Greece, CLIN EXP RH, 17(2), 1999, pp. 256-259